As Canada gets closer to the legalization of recreational cannabis, many experts have debated the supply and demand relationship for the legal product the market will produce.

Observers of the industry have noted that licensed producers (LPs) have failed to disclose information on a material level as far as size of inventories in grams produced.


“Unfortunately, not all of the LPs are reporting the size of their inventories in grams, with the three largest LPs in terms of the dollar amount of inventory silent on the issue,” Alan Brochstein, cannabis analyst with 420 Investor, wrote in a column addressing the shortage.

With legalization looming, here the Investing News Network (INN) provides an overview of some of the most recent opinions on the projected shortage facing the Canadian cannabis market.

Brochstein cautioned excited investors by arguing that a slow-to-start distribution network combined with limited inventory may lead to a “large initial imbalance between supply and demand.”

He wrote, “[i]f one assumes the demand among 6 [percent] of the population to be 1 gram per day, another 6 [percent] consumes 5 grams per month and 15 [percent] consume just a gram per month, the annual demand based on 36 million residents would amount to 982 million grams in a mature market.”

Brochstein also warned investors that although the Canadian market resembles the state of Colorado during 2014, there are “relatively few large-scale cannabis producers in Canada today.”

Voices denying the shortage claims

In December, Vice News reported on an unpublished study from Health Canada showing that the discussed shortage won’t manifest itself as indicated by other studies and predictions.

Miles Light, co-founder of the Marijuana Policy Group, told Vice News the analysis done by his firm shows it is “very unlikely” for an acute shortage of legal cannabis. The projections from Light indicate there will 500,000 kilograms of “flower-equivalent” product ready to be sold.

“Light claims the misconception around weed supply is a failure to recognize how large and well-financed Canadian licensed producers are,” Vice News wrote.

Last year, as concerns grew that a shortage would cause medical patients to miss out on cannabis product, Health Canada quickly issued a response denying patients were short on medicine.

Prominent CEO not worried about oversupply of legal cannabis

Chuck Rifici, CEO of Cannabis Wheaton Income (TSXV:CBW), said during an investing panel at the Lift & Co. Expo in Toronto in May that he believes every legal gram produced in Canada for at least the next five years will be sold.

“I’m not really worried about oversupply, and five years in cannabis years is a lifetime,” Rifici told the audience as the question of potential oversupply came up during the panel.

When asked about the cannabis public market landscape for mid- and small-market-cap companies, Aaron Salz, CEO of Stoic Advisory, told INN it is clear for him that oversupply is coming to the space.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

“In our model, we have 2 to 2.5 million kilos of funded capacity, Salz said. “In Canada, at its absolute peak, they only demand a million kilos, years from now.” He continued, “I think for a lot of these companies, from the mid to small caps, start to think ‘how do we actually differentiate our strategy.'”

Could a shortage lead to lack of medical product?

In April, CBC reported on a new research effort from the C.D. Howe Institute warning the Canadian federal government that its efforts against the black market won’t be enough.

“The clear economic logic is that so long as there is demand beyond what the legal industry can supply when new legislation takes effect … a market supplied by criminals will continue to exist,” CBC wrote.

Rosalie Wyonch, economist and policy analyst with the C.D. Howe Institute, said the main concern for the federal government should be supply. She also told CBC there is concern for medical product supply from legal producers in Canada.

“There’s nothing to incentivize producers to prioritize medical consumers, and in fact because of contractual arrangements to supply retail stores, they may actually be incentivized to supply the recreational market over the medical market,” Wyonch said.

During an interview with INN last year, Neal Gilmer, equity research analyst with Haywood Securities covering the cannabis public space, said he expected to see Health Canada step in and implement some sort of protection for medical patients.

“That’s just my expectation, I haven’t seen anything in writing anywhere,” he told INN in July.

Don’t forget to follow us @INN_Cannabis for real-time news updates! Stay tuned to our cannabis channel for more stories from Lift.

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less